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        Protective immunity elicited by T cell  –  depen-
dent antigens may last for decades without fur-
ther exposure to the immunizing antigen (  1, 2  ), 
and the memory B (B  Mem  ) cells serve an impor-
tant role in sustaining humoral immunity. A de-
fi  ning characteristic of B  Mem   cells is their ability 
to respond rapidly upon reencounter with their 
cognate antigens. Most B  Mem   cells in humans are 
characterized by their expression of CD27 and 
switched Ig isotype (  3  –  5  ). However, recent re-
ports describe an additional population of tissue-
based B  Mem   cells that do not express CD27 (  6  –  9  ) 
but instead express Fc receptor  –  like 4 (FCRL4) 
(  7  ). FCRL4 is a member of a recently identifi  ed 
family of transmembrane proteins with immuno-
regulatory potential, fi  ve of which display prefer-
ential B cell expression (for review see reference 
  10  ). Originally identifi  ed as a translocation fusion 
partner in a myeloma cell line, FCRL4 was 
named immunoreceptor superfamily translo-
cation-associated 1 (  11  ), and an independent 
identifi  cation through its sequence similarity to 
known Fc receptors led to the name Fc receptor 
homologue 4 (  12  ). A unifi  ed nomenclature was 
recently adopted in which this gene was renamed 
  FCRL4   (  13  ). 
  FCRL4 expression is restricted to a subpop-
ulation of B  Mem   cells with a distinctive phenotype 
and tissue localization pattern (  7, 14  ). Its intracel-
lular domain contains three consensus immuno-
receptor tyrosine-based inhibition motifs, and 
coligation of FCRL4 with the BCR aborts BCR-
mediated signaling via recruitment of the Src 
homology 2 domain  –  containing phosphatase 1 
(SHP-1) and/or SHP-2 tyrosine phosphatases (  15  ). 
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  Morphologically and functionally distinct subpopulations of human memory B (B  Mem  ) cells 
are identifi  able by either their expression of CD27 or Fc receptor  –  like 4 (FCRL4), an immuno-
globulin domain containing a receptor with strong inhibitory potential. We have conducted 
comparative transcriptome and proteome analyses of FCRL4  +   and FCRL4        B  Mem   cells and 
found that these two subsets have very distinctive expression profi  les for genes encoding 
transcription factors, cell-surface proteins, intracellular signaling molecules, and modifi  ers 
of the cell-cycle status. Among the differentially expressed transcription factors, runt-
related transcription factor 1 (RUNX1) transcript levels were up-regulated in FCRL4        cells, 
whereas RUNX2 transcripts were preferentially detected in FCRL4  +   cells. In vitro evidence 
for FCRL4 promoter responsiveness and in vivo promoter occupancy suggested that RUNX 
transcription factors are involved in the generation of these B  Mem   cell subpopulations. A 
distinctive signature profi  le was defi  ned for the FCRL4  +   B  Mem   cells by their expression of 
CD11c, receptor activator for nuclear factor     B ligand, and FAS cell-surface proteins, in 
combination with increased levels of   SOX5  ,   RUNX2  ,   DLL1  , and   AICDA   expression. We con-
clude that this recently identifi  ed subpopulation of B  Mem   cells, which normally resides in 
epithelial tissue-based niches, may serve a unique role in mucosal defense and, conversely, 
as a target for neoplastic transformation events. 
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these two B  Mem   cell subpopulations. This transcriptome analysis 
revealed a surprisingly large number of diff  erentially expressed 
genes. Using this gene expression data as a starting point, we 
obtained evidence indicating that diff  erences in transcription 
factors, cell-surface receptors, and cell-cycle status character-
ize the diff  erentiation profi  les that distinguish these two B  Mem   
cell subpopulations. 
    RESULTS   
  Transcriptome profi  les differ for FCRL4  +   
and FCRL4        B  Mem   cells 
  A comparison of transcripts expressed by FCRL4  +   versus 
FCRL4        B  Mem   cells was conducted by a gene array analysis 
of tonsillar tissues from three young donors, none of whom 
showed signs of illness at the time of tonsillectomy. This com-
parison led to the identifi  cation of 164 transcripts that were 
expressed with a greater than fourfold diff  erence by the two 
The FCRL4  +   cells are rarely seen in the bone marrow, blood, 
and spleen, but are found instead in the crypt epithelium and 
perifollicular regions of the palatine tonsils, intestinal lymphoid 
tissues, and mesenteric lymph nodes, wherein their numbers 
are increased in patients with lymphadenitis caused by   Toxo-
plasmosis gondii  , HIV-1, and EBV infections (  7, 14, 16  ). Most 
of the FCRL4  +   tissue-resident cells do not express CD27, the 
currently favored marker for human B  Mem   cells. Although the 
FCRL4       /CD27  +   B  Mem   cells respond vigorously to in vitro 
stimulation by T cell  –  derived cytokines (IL-2 and IL-10) and 
CD40L or BCR ligation, the FCRL4  +   cells preferentially re-
spond to T cell cytokines and CD40L alone (  7  ). The relatively 
large FCRL4  +   B  Mem   cells and the relatively small FCRL4        
B  Mem   cells thus represent morphologically, topographically, and 
functionally distinguishable subpopulations. 
  To gain additional insight into their diff  erentiation status 
and function, we examined the transcript expression profi  les of 
    Figure 1.         Transcriptome analysis of FCRL4  +   and FCRL4            B  Mem   cells.   The transcripts differentially expressed by FCRL4  +   and  FCRL4       B Mem   from  three 
independent tonsillar cell preparations are displayed. Up- and down-regulated transcripts are indicated in red and green, respectively. The magnitude of 
expression is depicted by the color bar. Arrowheads indicate transcripts whose expression was validated by quantitative RT-PCR and/or by FACS analysis 
of other tonsillar samples.     JEM VOL. 205, August 4, 2008 
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B cells has also been observed (  17  –  20  ). As would be antici-
pated, signifi  cant diff  erences in transcription levels were not 
detected for the prototypical B cell src kinase LYN (  Fig. 2 B  , 
top). Overall, this transcriptome analysis revealed a relatively 
large number of transcripts (128) with increased levels of ex-
pression in FCRL4  +   cells, and a more limited set of transcripts 
(36) with increased expression levels in FCRL4        cells. 
  Distinctive surface marker profi  le of FCRL4  +   cells 
  We performed quantitative RT-PCR and FACS profi  le ana-
lyses to verify the diff  erential expression of transcripts for cell-
surface receptors that might be useful in distinguishing the 
two B  Mem   cell populations ( Fig. 3 ).   Flow cytometric immuno-
fl  uorescence analysis confi  rmed that the FCRL4  +   cells ex-
press relatively high levels of CD95 (FAS) in comparison 
with FCRL4        cells. Interestingly, the FCRL4  +   B  Mem   cells 
expressed CD11c, and most were negative for cell-surface 
CD11b, whereas the opposite was true for the FCRL4        B  Mem   
cells. The FCRL4        cells also preferentially expressed CD31, 
and a substantial subpopulation of these cells expressed CD23. 
In accord with previous results (  7  ), FCRL4  +   B  Mem   cells ex-
pressed higher surface levels of CD20 and lower levels of 
CD21 than their FCRL4        counterparts. Finally, in keeping 
with the relatively high levels of RANKL mRNA expression, 
we observed higher cell-surface RANKL expression levels 
for the FCRL4  +   B  Mem   cells by immunofl  uorescence analysis 
(  Fig. 2 A and Fig. 3  ). Thus, in addition to their expression of 
FCRL4, this subpopulation of B  Mem   cells was found to have the 
following characteristic cell-surface profi  le: CD11c  +  , CD20  hi  , 
CD31       , CD95  +  , and RANKL  +  . 
  Cell-cycle status of FCRL4  +   versus FCRL4        B  Mem   cells 
  The gene array data indicated relatively high expression levels 
in the FCRL4  +   cells for several genes regulating entry and pro-
gression through the cell cycle. Quantitative RT-PCR con-
fi  rmed that these transcripts, including several cyclins as well 
as the cell division cycle 2 kinase subunit of the M-phase pro-
moting factor, were increased in the FCRL4  +   subpopulation 
of B  Mem   cells (  Fig. 4  ).   Ki-67, a nuclear protein preferentially 
expressed by cycling cells, was among the transcripts with in-
creased expression levels in FCRL4  +   cells (  Fig. 1  ). Using Ki-67 
and propidium iodide costaining, which allows the discrimi-
nation of cells in the G  0   versus the G  1   phase of the cell cycle, 
we found a substantial fraction of the FCRL4  +   population 
(42.8%   ±   18.3 SEM;   n   = 4) to be in the G  1   phase; smaller 
fractions of S-phase and G  2  /M-phase cells were also observed 
(  Fig. 4 B  ). In contrast, the cells in the FCRL4        population 
were almost all in the G  0   phase (95.8%   ±   1.1 SEM;   n   = 4). In 
the representative experiment shown in   Fig. 4 B  , note that 
cells in the G  0   phase are located in the bottom left quadrant of 
the FACS profi  le and cells in the G  1   phase are in the top left 
quadrant; cells in the S, G  2  , and M phases of cell cycle are 
located in the top right quadrant. In conclusion, the fi  ndings 
of heightened expression of genes regulating entry and pro-
gression through the cell cycle provide evidence for prior ac-
tivation of the relatively large FCRL4  +   B  Mem   cells. 
B  Mem   cell populations. The large array of diff  erentially ex-
pressed genes revealed in this analysis included ones encod-
ing transcription factors, cell-cycle modulators, cell-surface 
molecules, and components of signal transduction cascades. 
  Fig. 1   shows a heat map of the diff  erentially regulated transcripts.   
The majority of these up-regulated genes were identified 
in the FCRL4  +   cells. Not surprisingly, FCRL4 was among 
the strongly up-regulated transcripts in the FCRL4  +   popu-
lation, as were CCR1 transcripts, in keeping with a previ-
ous analysis ( 7  ). Surprisingly, one of the strongly up-regulated 
transcripts encoded receptor activator for NF-    B ligand 
(RANKL), and this unanticipated fi  nding was confi  rmed by 
quantitative RT-PCR analysis and measurement of protein 
expression in other tonsil samples (  Fig. 2 A  ).   Quantitative 
RT-PCR analyses likewise confi  rmed the higher expression 
levels of runt-related transcription factor 2 (RUNX2) and 
SRY-box 5 (SOX5) for the FCRL4  +   B  Mem   cells and rela-
tively higher RUNX1 expression by FCRL4        B  Mem   cells 
(  Fig. 2 B  ). The diff  erential expression patterns observed for 
several src kinase family members were similarly validated: 
FCRL4  +   cells expressed higher levels of hemopoietic cell 
kinase (HCK) and FGR, but lower levels of lymphocyte-
specifi  c protein tyrosine kinase (LCK), than FCRL4        cells. 
Although LCK is typically considered a T cell  –  specifi  c src 
family kinase, LCK expression in B cell lines and primary 
    Figure 2.         Genes differentially expressed by FCRL4  +   and FCRL4            
B  Mem   cells.   (A) RANKL transcript (top) and protein (bottom) levels in FCRL4  +  
and FCRL4        B Mem   cells. RANKL mRNA levels were determined by quantita-
tive RT-PCR normalized to   RP-2  . Values represent mean   ±   SEM (  n   = 3), and 
statistical signifi  cance was determined using the paired Student  ’  s   t   test. 
RANKL protein was quantitated by examining the mean fl  uorescence inten-
sity levels for RANKL on FCRL4  +   and  FCRL4       B Mem   cells, normalized to the 
mean fl  uorescence intensity levels of isotype control antibodies in the cor-
responding cell populations. Values represent mean   ±   SEM (  n   = 16), and 
statistical signifi  cance was determined using the paired Student  ’  s   t   test. 
(B) Quantitative RT-PCR analysis of the indicated src family kinases (top), or 
DLL1 and transcription factor transcripts (bottom) in FACS-sorted FCRL4  +  
and FCRL4        B Mem   cells. Values represent mean   ±   SEM (  n   =  4).   1810 MEMORY B CELL SUBSETS   | Ehrhardt et al. 
  Differential transcription factor expression 
by B  Mem   cell subpopulations 
  One of the goals in this comparison of transcripts expressed 
by FCRL4  +   versus FCRL4        cells was to gain a better view of 
the diff  erentiation status of these B  Mem   cell subpopulations. 
Diff  erentially expressed transcription factors were therefore of 
particular interest. The SOX5 transcription factor was among 
the strongly up-regulated transcripts observed for FCRL4  +   cells 
in the gene array analysis (  Fig. 1  ). This member of the SRY-
box  –  containing family of transcription factors was expressed 
in FCRL4  +   cells at     12-fold higher levels than in FCRL4        
cells, a fi  nding that was confi  rmed by quantitative RT-PCR 
(  Fig. 2 B  ). We found that, in addition to SOX5, the RUNX2 
transcription factor was preferentially up-regulated in FCRL4  +   
cells. In contrast, quantitative RT-PCR indicated that RUNX1 
was expressed at higher levels in FCRL4        cells, although just 
outside the parameters used for inclusion of diff  erentially ex-
pressed transcripts in the gene array assessment. Expression of 
the   RUNX   genes is regulated by two separate promoters. In 
the B  Mem   cell populations analyzed, the RUNX1 transcripts 
were initiated from the distal promoter (P1) in FCRL4        cells, 
whereas transcription of three diff  erent RUNX2 isoforms was 
initiated from the proximal promoter (P2) by cells of the 
FCRL4  +   population (Fig. S1, available at http://www.jem
.org/cgi/content/full/jem.20072682/DC1). 
  FCRL4 promoter responsiveness to Runx transcription factors 
  To address the possibility that the   FCRL4   gene is regulated by 
these diff  erentially expressed transcription factors, we cloned 
the putative promoter region, a genomic fragment extend-
ing 2,600 bp upstream of the initiating ATG, into a lucif-
erase reporter construct. Sequence analysis of this putative 
promoter region identifi  ed eight potential RUNX binding 
sites and one SOX5 binding site (  Fig. 5 A  ).   Cotransfection 
of the FCRL4 reporter plasmids with RUNX1 or RUNX2 
expression vectors resulted in little or no detectable activa-
tion. However, the putative   FCRL4   promoter activated the 
reporter gene   robustly after cotransfection of RUNX1 with 
core-binding factor      (CBF    ), its normal heterodimeric part-
ner. Conversely, limited reporter gene activity was observed 
    Figure 3.         Expression of cell-surface antigens on human B  Mem   cell populations.   FACS analysis of tonsillar lymphocytes was performed for the indi-
cated markers by gating on the B  Mem   cell population (CD19  + ,  IgD     ,  CD38      ). Representative FACS profi  les from at least 12 analyzed tonsillar preparations 
are  depicted.   
    Figure 4.         Cell-cycle phenotype of FCRL4  +   and FCRL4            B  Mem   cells.   (A) Quantitative RT-PCR analysis of the indicated transcripts. Values were nor-
malized to RP2 expression and are displayed as the mean ratio of FCRL4  + /FCRL4        ±   SEM  ( n   = 5 independent PCRs on independent tonsil preparations). 
(B) Staining of FACS-sorted FCRL4  +   and  FCRL4       B Mem   cells for DNA content and Ki67 expression. Shown is a representative example of four independent 
tonsillar B  Mem   cell preparations. Numbers in the top right of each FACS blot indicate the percentage of cells in each quadrant.     JEM VOL. 205, August 4, 2008 
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FCRL4  +   cells approached those observed for the pre  –  germinal 
center (GC) and GC B cells, even though the GC-specifi  c 
transcription factor B cell lymphoma 6, which serves to main-
tain the proliferative status of GC B cells, was not expressed 
above background levels by either B  Mem   cell subpopulation. 
We also confi  rmed that neither of the B  Mem   cell subpopula-
tions expressed B lymphocyte  –  induced maturation protein 1 
(  Fig. 6  ) or X-box binding protein 1s (XBP1s [the spliced 
isoform of XBP1]; not depicted) transcripts, which are ex-
pressed exclusively by cells undergoing plasma cell diff  erenti-
ation. In addition to their preferential expression of FCRL4, the 
FCRL4  +   B  Mem   cells also proved to be distinguishable from B 
cells at other stages of diff  erentiation by their expression of 
RANKL, RUNX2, and SOX5. In contrast, although the 
higher expression patterns for lipocalin 10, prickle-like 1,     -site 
amyloid precursor protein  –  cleaving enzyme 2, and endo-
thelial diff  erentiation gene 1 transcripts in FCRL4        B  Mem   
cells could be confi  rmed by quantitative RT-PCR, none of 
these transcripts were found to be exclusively expressed by 
this subpopulation of B lineage cells. In conclusion, this anal-
ysis provides a distinctive gene expression signature for the 
FCRL4  +   B  Mem   cells, featuring the preferential expression of 
  RANKL  ,   SOX5  , and   RUNX2   in combination with shared 
expression of   AICDA  . 
    DISCUSSION   
  This comparative analysis of the transcripts preferentially ex-
pressed by FCRL4  +   B  Mem   cells versus those expressed by the 
FCRL4        B  Mem   cells reveals intriguing diff  erences in their gene 
expression profi  les. The diff  erentially expressed transcripts fall 
into several categories: transcription factors, DNA-modifying 
enzymes, cell-cycle regulators, adhesion molecules, homing 
after cotransfection of the RUNX2-isoforms with CBF    . 
Cotransfection of SOX5 with CBF     and either RUNX1 or 
RUNX2 did not lead to any diff  erence in reporter gene ac-
tivity (  Fig. 5 B  ). As a control we transfected the paired box 
5 B cell transcription factor, which has no binding sites in 
the   FCRL4   promoter, and observed no promoter activa-
tion (  Fig. 5 B  ). 
  Because the reporter gene activation assays indicated the 
potential of RUNX1 and, to a lesser degree, RUNX2 to 
regulate the   FCRL4   promoter, we performed chromatin 
immunoprecipitation (ChIP) followed by quantitative PCR to 
determine whether RUNX transcription factors occupy the 
  FCRL4   promoter in primary tonsillar B  Mem   cells. Signifi  cant 
RUNX2 binding to   FCRL4   promoter sequences was not 
detected in these experiments (unpublished data). However, 
we found that endogenous RUNX1 bound to promoter region 
sequences of   FCRL4   in FCRL4        cells but not in FCRL4  +   
cells (  Fig. 5 C  ). These fi  ndings are consistent with a func-
tional role for RUNX1 in the diff  erential transcriptional reg-
ulation of the B  Mem   cell subpopulations. 
  Signature transcript expression profi  les 
for B  Mem   cell populations 
  In a search for genes preferentially expressed in one or the other 
of these two subpopulations of B  Mem   cells and not in other 
stages of B cell diff  erentiation, we selected a panel of the dif-
ferentially expressed genes for comparative analysis at all stages in 
the diff  erentiation of peripheral B cells (  Fig. 6  ).   Notch ligand 
delta-like 1 (DLL1) was found to be expressed at relatively 
high levels by naive B cells as well as FCRL4  +   B  Mem   cells. 
Interestingly, the expression levels of activation-induced cyt-
idine deaminase (AICDA), more commonly known as AID, in 
    Figure 5.         RUNX1 responsiveness of the   FCRL4   gene promoter.   (A) Analysis of the putative promoter sequence of the   FCRL4   gene. Locations are 
indicated for potential RUNX (open circles) and SOX5 (closed triangle) binding sites. (B) Luciferase reporter gene studies on transiently transfected 293T 
cells. Cells were transfected with the putative promoter of the   FCRL4   gene controlling expression of the luciferase reporter gene and expression vectors 
containing the indicated transcription factors. RUNX2     5 and RUNX2     5,7 are splice isoforms that lack exon 5 and exons 5 and 7, respectively (see also 
Fig. S1, available at http://www.jem.org/cgi/content/full/jem.20072682/DC1). Values represent mean   ±   SD (  n   = 5). (C) ChIP assay of RUNX1 binding in 
FACS-sorted FCRL4  +   and  FCRL4       B Mem   cells. Positions of the amplifi  ed PCR fragments are indicated by closed rectangles in A. Open bars indicate signals 
obtained from FCRL4  +   cells, and shaded bars indicate signals obtained from FCRL4        cells. All values were normalized to the PCR signal obtained from 
control immunoprecipitates (anti  –  SHP-1), as well as to unrelated, nonspecifi  cally copurifi  ed DNA (CCR4). Values represent mean   ±   SEM (  n   = 5). Statistical 
signifi  cance of P < 0.05 is indicated by an asterisk.     1812 MEMORY B CELL SUBSETS   | Ehrhardt et al. 
scription factors could modulate expression of   FCRL4   itself. 
Alternatively, they may infl  uence other target genes that deter-
mine the distinctive B  Mem   cell diff  erentiation patterns. We 
identifi  ed multiple potential RUNX binding sites in the 
predicted promoter region 2.6 kb upstream of the   FCRL4   
gene, and reporter gene analysis indicated RUNX1/CBF     
responsiveness for this putative FCRL4 promoter region. 
Preferential RUNX2 mRNA expression was observed for 
the FCRL4  +   B  Mem   cells and, when overexpressed in reporter 
gene expression studies, RUNX2 activated the   FCRL4   pro-
moter, albeit to a modest extent. However, we were unable 
to demonstrate the involvement of this transcription factor 
in the regulation of FCRL4 expression. The same was true 
for SOX5, the other transcription factor for which we found 
elevated expression in FCRL4  +   B  Mem   cells. Our fi  ndings to 
date are thus more consistent with the possibility that other 
genes whose transcripts make up the distinctive transcriptome 
of FCRL4-bearing B  Mem   cells are infl  uenced by these two 
transcription factors. Somewhat paradoxically, ChIP assays 
indicated RUNX1 occupancy of the   FCRL4   promoter re-
gion in primary FCRL4        B  Mem   cells, a fi  nding suggesting that 
RUNX1 may negatively regulate this promoter in vivo. 
A negative regulatory role for RUNX1 has indeed been 
described in lymphocytes, most recently with the fi  nding of 
Th-inducing POZ/Kr  ü  ppel-like factor repression in CD8  +   T 
cells (  30  ). Although RUNX1 can associate with the corepres-
sor mSin3A in the absence of extracellular signal-regulated 
kinase  –  mediated RUNX1 phosphorylation, the corepressor 
receptors, signal transduction intermediates, apoptosis-regulat-
ing molecules, and receptors that may induce activation and 
diff  erentiation by cells of other lineages. 
  One defi  ning characteristic of the FCRL4  +   and FCRL4        
populations of B  Mem   cells is their reciprocal expression of the 
RUNX1 and RUNX2 transcription factors that have impor-
tant developmental roles. Our data suggest that these tran-
scription factors may also infl  uence B  Mem   cell diff  erentiation 
decisions. The three mammalian   Runx   genes are homologues 
to the   Drosophila     runt   gene that has an essential role in estab-
lishing the embryonic segmental body pattern (  21  ). All three 
of these highly conserved genes encode transcription factors 
that recognize the same DNA binding sequence, and each hetero-
dimerizes with the CBF     transactivation unit (for review see 
references   22, 23  ). RUNX1 appears to be important for hemo-
poietic development because mice with targeted disruption 
of the   Runx1   locus die early in embryogenesis without defi  n-
itive hemopoiesis (  24  ). However, inducible   Runx1   knockout 
studies suggest that this gene does not aff  ect general hemo-
poiesis in adult life, where its absence instead leads to reduced 
lymphocyte numbers and a myeloproliferative phenotype (  25  ). 
Runx1 cooperates with early B cell factor to activate the   mb-1   
gene during B lineage diff  erentiation (  26  ). Runx2, a master 
regulator for bone development (  27, 28  ), may similarly con-
tribute to the regulation of many genes in addition to those 
controlling osteogenesis (  29  ). 
  Our analysis of B  Mem   cell subpopulations suggests that 
diff  erential expression of the RUNX1 and RUNX2 tran-
    Figure 6.         Differentially regulated transcripts in FCRL4  +   and FCRL4            B  Mem   cells in comparison with other stages in B cell differentiation.  
Analysis of expression levels of the indicated transcripts in naive B, pre  –  GC B (preGC B), GC B (GC B), FCRL4  +   and  FCRL4       B Mem  , and plasma cells. All val-
ues are normalized to RP2 expression. Error bars indicate one SEM (  n   =  3).   JEM VOL. 205, August 4, 2008 
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of EDG1 expression, a gene demonstrated to be crucial for 
lymphocyte egress from lymphoid tissues (  40  ), would also fa-
vor the tissue-resident status of this B  Mem   cell population. 
  It is intriguing that the FCRL4  +   cells express higher levels 
of CD95 (FAS) than the FCRL4        B  Mem   cells in that elimina-
tion of lymphocytes is a key requirement both for the devel-
opment of an appropriate lymphocyte repertoire and for the 
termination of an immune response. The elevated FAS level 
may not necessarily translate into increased potential to un-
dergo apoptosis, however, because IL-4 and BCR ligation 
can counteract FAS-induced B cell apoptosis (  41  ). The com-
paratively high level of AICDA expression found to charac-
terize the FCLR4  +   B  Mem   cells was also surprising, because 
increased levels of FAS and AICDA expression typify GC B 
cells. The shared absence of CD38 on both the FCRL4  +   and 
FCRL4        subpopulations of B  Mem   cells and their limited ex-
pression of B cell lymphoma 6, B lymphocyte  –  induced mat-
uration protein 1, and XBP1s transcripts nevertheless suggests 
that neither B  Mem   cell subpopulation has recently left the GC 
nor is undergoing terminal plasma cell diff  erentiation. Although 
AICDA expression by B cells is indispensable for somatic hyper-
mutation and class switch recombination within the GC, this 
enzyme may also be expressed by B cells outside of the GC, 
notably by large interfollicular B cells with many similarities 
to FCRL4-bearing B  Mem   cells (  42  –  45  ). This raises the issue of 
whether FCRL4  +   B  Mem   cells may merely maintain AICDA 
expression after their exit from the GC or have been induced 
elsewhere to express AICDA to undergo somatic hypermu-
tation and class switch recombination. The latter possibility 
gains support from recent studies suggesting that B  Mem   cells 
may also be generated outside the GC (  42, 46  ). Irrespective 
of the derivation of FCRL4  +   cells, AICDA-induced geno-
mic instability could potentially put them at increased risk for 
chromosomal translocation events and malignant transforma-
tion. In that regard, it is interesting to note that   FCRL4   was 
originally identifi  ed in a myeloma cell line as a gene involved 
in a translocation event on chromosome 1q21, a genetic re-
gion known as a   “  hot spot  ”   for the somatic mutations and 
chromosomal translocations often found in B cell malig-
nancies (  11  ). 
  Our studies emphasize the diff  erences between FCRL4  +   
and FCRL4        B  Mem   cells, but the possibility of a precursor  –
  progeny relationship is raised by certain shared features. Al-
though most FCRL4  +   B  Mem   cells are CD27        and virtually all 
of the FCRL4        B  Mem   cells are CD27  +  , some of the FCRL4  +   
cells express CD27 (  7  ). This fi  nding could suggest a CD27  +   
B  Mem   cell transition to become a FCRL4  +   B  Mem   cell, or vice 
versa (  7  ). As one means of testing the fi  rst possibility, we ex-
amined the ability of FCRL4        cells to express FCRL4 after 
in vitro treatment with a variety of B cell stimuli, but without 
success (unpublished data). Nevertheless, in lieu of knowledge 
about the essential physiological conditions that infl  uence the 
diff  erentiation of these B  Mem   cell subpopulations, a precursor  –
  progeny relationship remains a possibility. 
  The FCRL4  +   B  Mem   cells were notably characterized by 
their increased levels of RANKL and DLL1. Animal models 
interaction is lost and protein stability is diminished after mi-
togen-activated protein kinase  –  mediated phosphorylation of 
serine residues 249 and 266 (  31  ). A negative RUNX1 regula-
tory function would thus be favored by the G  0   cell-cycle sta-
tus of most FCRL4        cells, during which limited extracellular 
signal-regulated kinase activity would be anticipated. 
  A signifi  cant fraction of the diff  erentially expressed tran-
scripts that we identifi  ed encode genes involved in regulation 
of the cell cycle. The pronounced up-regulation of these genes 
in the FCRL4  +   B  Mem   cells accords with our demonstration 
that     35% of the cells in this population are in the G1 phase 
of the cell cycle. The observation that tissue-resident FCRL4  +   
cells often express nuclear Ki-67 further supports the notion 
that these cells have recently undergone activation. These 
  indications of a primed cell status could refl  ect the physical 
localization of the FCRL4  +   B  Mem   cells in the mucosal tissues 
in close proximity to the natural microfl  ora and potential 
pathogen invaders. 
  The diff  erential expression patterns for CD11b and CD11c 
provide additional discriminating cell-surface markers for dis-
tinguishing these B  Mem   cell subpopulations. The FCRL4  +   cells 
preferentially express CD11c and have lower levels of CD11b. 
Indeed, FCRL4 and CD11c expression are entirely concomi-
tant on primary tonsillar B cells. Although commonly used as 
a dendritic cell marker, CD11c is also expressed by activated 
B cells and B cell leukemias (  32, 33  ). Through their hetero-
dimerization with CD18, the CD11b and CD11c transmem-
brane proteins function both as complement receptors and 
adhesion molecules. The ligands identifi  ed for CD11b and 
CD11c, including iC3b, fi  brinogen, and intracellular adhe-
sion molecules 1 and 2, are largely shared. One interesting 
diff  erence is that CD11c recognizes acidic residues on fi  -
brinogen with much higher affi   nity than does CD11b (  34  ). 
The accessibility of negatively charged residues is notably 
increased in structurally compromised proteins, such as the 
proteolytically cleaved fi  brinogen that accompanies infection. 
Although fi  brinogen is synthesized primarily by hepatocytes, 
epithelial cells also have the capacity to produce fi  brinogen 
(  35, 36  ). The expression of CD11c on FCRL4  +   B  Mem   cells 
could therefore contribute to their preferential localization in 
lymphoid tissues along the mucosal borders. Similarly, their 
heightened expression of chemokine receptors, CCR1 and 
CCR5, may support homing of the FCRL4  +   B  Mem   cells to 
tissues with ongoing infl  ammation. The increased expression 
levels of FGR and HCK by the FCRL4  +   B  Mem   cells is also 
noteworthy in this context, in that these src family kinases 
have been implicated in the regulation of signaling induced 
by macrophage infl  ammatory protein 1    , one of the ligands 
for CCR1 and CCR5 (  37  ). Another distinctive cell-surface 
feature of FCRL4  +   cells is the absence of CD31 (platelet/
endothelial cell adhesion molecule 1), whereas most FCRL4        
B  Mem   cells express this receptor. CD31 on circulating leuko-
cytes functions as a facilitator of extravasation, in addition to 
its immunoregulatory activity on BCR signaling (  38, 39  ). Its 
absence on the FCRL4  +   B  Mem   cells thus could contribute to 
their preferential tissue-based localization. Similarly, the lack 1814 MEMORY B CELL SUBSETS   | Ehrhardt et al. 
pensions were generated by tissue mincing, fi  ltration through a 70-  μ  m wire 
mesh, and centrifugation on a Ficoll-Hypaque gradient. Tonsillar B cells 
were negatively selected using the B cell isolation kit II (Miltenyi Biotec) 
according to the manufacturer  ’  s instructions. The isolated cells were typi-
cally   >  99.5% CD19  +   B cells. The resulting tonsillar B cells were stained for 
CD38 and IgD expression, and, to further exclude potential contamination 
with non  –  B cells, also with anti-CD19 antibodies. B  Mem   cells were identifi  ed 
as CD19  +  , CD38       , IgD        cells. Costaining with biotinylated F(ab    )  2   frag-
ments of FCRL4 antibodies and streptavidin-allophycocyanin allowed the 
purifi  cation of FCRL4  +   and FCRL4        B  Mem   cells using a FACS sorter (Mo-
Flow; Dako). 
  Transcript analysis of FCRL4  +   and FCRL4         B  Mem   cells.     Total RNA 
from     250,000 cells from each purifi  ed population was extracted using 
an RNeasy kit (QIAGEN), and RNA integrity was assessed using a bio-
analyzer (Agilent Technologies). cDNA synthesis, aRNA amplifi  cation, 
biotinylation, and fragmentation were performed with a Two-Cycle Tar-
get Labeling kit (Aff  ymetrix). 15   μ  g of labeled samples were added to 
the hybridization cocktail and hybridized with Human Genome U133 Plus 
2.0 GeneChips (Aff  ymetrix) at 45  °  C for 16 h, as described in the man-
ufacturer  ’  s instructions. Washing and streptavidin-phycoerythrin staining 
were conducted using a GeneChip Fluidics Station (Aff  ymetrix); the chips 
were scanned using a GeneChip Scanner 3000 (Aff  ymetrix). The normal-
ized hybridization intensity for each probe set was calculated using the 
GC-RMA method (  53  ) implemented in the GeneSpring software pack-
age (Agilent Technologies) as the default setting. Statistical analysis of the 
gene expression between FCRL4  +   and FCRL4        cells was performed with 
the Rank products method (  54  ) implemented in the Bioconductor package 
(http://www.bioconductor.org). Genes for which the percentage of false 
positives was   <  0.05 were considered as signifi  cantly diff  erentially expressed. 
The microarray data were deposited in the Center for Information Biology 
Gene Expression Database (available at http://cibex.nig.ac.jp/) under acces-
sion no. CBX40. 
  Quantitative RT-PCR.     Transcripts found to be diff  erentially expressed by 
gene array were confi  rmed by quantitative RT-PCR using the SYBR-
Green PCR Master Mix (Applied Biosystems) on a sequence detection sys-
tem (7900HT; Applied Biosystems). To this end, FCRL4  +   and FCRL4        
B  Mem   cells (CD19  +  , CD38       , IgD       ) were purifi  ed using a MoFlow FACS 
sorter. RNA was prepared using the QIAGEN RNeasy kit, and random-
primed cDNA was generated using SuperScript II (Invitrogen), according to 
the manufacturer  ’  s instructions. To prevent the potential contamination of 
the RNA samples with genomic DNA, all RNA preparations were DNase 
treated. Gene-specifi  c primers (primer sequences are available in Table S1, 
available at http://www.jem.org/cgi/content/full/jem.20072682/DC1) for 
the quantitative PCR were designed to overlap exon  –  intron borders to fur-
ther reduce the possibility of amplifi  cation of potentially contaminating ge-
nomic DNA. Because the   GAPDH   and       -actin   genes, which are commonly 
used for normalization purposes, can be subject to transcriptional regulation, 
we normalized all samples to   RNA polymerase II   (  RP-2  ) expression, because 
  RP-2   expression is relatively independent of transcriptional regulation in 
diff  erent cell types and tissues (  55  ). 
  FACS analysis.     FACS analysis was performed with a FACS Cyan instru-
ment (Dako). Purifi  ed tonsillar cells were blocked in the presence of 5% 
normal mouse serum and incubated with the antibodies indicated in the fi  g-
ures. For each of the cell-surface markers, at least eight independent tonsillar 
cell preparations were analyzed. For cell-cycle analysis, purifi  ed FCRL4  +   
and FCRL4        memory cells were fi  xed in 80% ice-cold ethanol. After fi  xa-
tion, the cells were incubated for 15 min with FITC-labeled Ki-67 anti-
bodies or isotype-matched control antibodies. The cells were then washed 
and resuspended in PBS containing 10 mg/ml RNaseA, followed by an 
additional incubation period of 10 min at 37  °  C. Propidium iodide was 
added to a fi  nal concentration of 20   μ  g/ml before analysis of the cells by 
fl  ow cytometry. 
with targeted deletions in the   Dll1   and   Rankl   genes have 
  severe developmental abnormalities of the immune system, 
thereby demonstrating the importance of these ligands for 
a functional immune system (  47  –  49  ). Unlike T cells, which 
are well recognized for their ability to directly and indirectly 
infl  uence the activation and diff  erentiation status of many 
cell types, B cells are known primarily for their ability to 
produce antibodies. Nevertheless, B cells may indirectly in-
fl  uence other cells as well, for example, by secreting the cy-
tokines IL-4, IL6, IL-12, and IFN-     (  50  ). The prominent 
expression of DLL1 and RANKL by FCRL4  +   B  Mem   cells 
implies that they also exert an instructive function through 
interaction with other cells expressing the cognate receptors 
for these ligands. We conclude that the distinctive signature 
expression patterns for receptors (CD11c, FCRL4, CCR1, 
CCR5, RANKL, and DLL1), signal transduction molecules 
(FGR and HCK), transcription factors (RUNX2 and SOX5), 
and AICDA, in combination with the diff  erential respon-
siveness to cytokines and BCR ligation that characterize these 
B  Mem   cell subpopulations (  7  ), indicate a unique diff  erentiation 
status for the FCRL4  +   B  Mem   cells. 
  The potent inhibitory potential of FCRL4 for BCR-me-
diated signaling (  15  ) implies a physiological role in immune 
responses of this distinctive subpopulation of B  Mem   cells. Con-
versely, FCRL4 dysfunction may contribute to B cell  –  me-
diated immunopathology. Although the B cells that express 
FCRL4 are normally retained in lymphoid tissues belonging to 
the mucosal immune system (  7, 14, 16  ), they may migrate else-
where under disease conditions. In HIV-1  –  infected patients, 
for example, wherein B cell compartmental perturbations char-
acterized by polyclonal B cell activation and hypergamma-
globulinemia may accompany the progressive depletion of 
CD4  +   T cells (  51  ), a prominent subpopulation of CD21  low  , 
CD95  high   peripheral blood B cells that is partially positive for 
Ki-67 has been previously described (  52  ). These cells have 
been recently shown to be functionally impaired FCRL4  +   B 
cells (Fauci, A.S., personal communication). Given the potent 
immunoregulatory potential of FCRL4, it will be interesting 
to determine if its dysfunction or disengagement contributes 
to the hyperactivation and displacement of B cells that are ob-
served in chronic HIV-1 infection. In conclusion, the results 
of this study further defi  ne the unique features that character-
ize the FCRL4  +   subpopulation of B  Mem   cells and emphasize 
their likely engagement in humoral immune defense of the 
epithelial boundaries of the body. 
  MATERIALS AND METHODS 
  Materials and reagents.     Antibodies used for FACS analysis were purchased 
from BD Biosciences unless otherwise indicated. Anti  –  Ki-67 was obtained 
from Vector Laboratories. F(ab    )  2   fragments of FCRL4 antibodies were de-
scribed previously (  7  ) Antibodies to RUNX1, RUNX2, and SHIP were 
obtained from Santa Cruz Biotechnology, Inc. Anti-RANKL antibodies 
were purchased from eBioscience. 
  Isolation of tonsillar B  Mem   cells.     Tonsil tissue samples were obtained 
from the human tissue procurement service of the University of Alabama 
at Birmingham with Institutional Review Board approval. Single-cell sus-JEM VOL. 205, August 4, 2008 
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PCR for CCR4, a gene that is not expressed in either memory subpopula-
tion (  7  ). Statistical signifi  cance was determined using the two-tailed Stu-
dent  ’  s   t   test. 
  Online supplemental material.     Fig. S1 shows a diagram of the amplifi  ed 
RUNX1 and RUNX2 splice isoforms. The exon  –  intron structures of the 
genes, and the positions of the promoters and the primers used for PCR am-
plifi  cation are indicated. Table S1 lists the oligonucleotide sequences for 
PCR reactions performed in this study. Online supplemental material is 
available at http://www.jem.org/cgi/content/full/jem.20072682/DC1. 
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